Related Experiment Video

Updated: May 9, 2026

Testing Cancer Immunotherapeutics in a Humanized Mouse Model Bearing Human Tumors
15:24

Testing Cancer Immunotherapeutics in a Humanized Mouse Model Bearing Human Tumors

Published on: December 16, 2022

Tumor growth rate as an intermediate trial endpoint

Gregory Goldmacher1

  • 1Clinical Imaging & Pathology, Merck & Co., Inc, Rahway, NJ, 07065, United States.

The Oncologist
|May 8, 2026
PubMed
Summary

No abstract available in PubMed .

More Related Videos

Generation of 3D Tumor Spheroids for Drug Evaluation Studies10:33

Generation of 3D Tumor Spheroids for Drug Evaluation Studies

Published on: February 24, 2023

Pretargeted Radioimmunotherapy Based on the Inverse Electron Demand Diels-Alder Reaction09:44

Pretargeted Radioimmunotherapy Based on the Inverse Electron Demand Diels-Alder Reaction

Published on: January 29, 2019

Related Concept Videos

Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...